Allosteric inhibition of complement function by a staphylococcal immune evasion protein

The complement system is a major target of immune evasion by Staphylococcus aureus. Although many evasion proteins have been described, little is known about their molecular mechanisms of action. Here we demonstrate that the extracellular fibrinogen-binding protein (Efb) from S. aureus acts as an allosteric inhibitor by inducing conformational changes in complement fragment C3b that propagate across several domains and influence functional regions far distant from the Efb binding site. Most notably, the inhibitor impaired the interaction of C3b with complement factor B and, consequently, formation of the active C3 convertase. As this enzyme complex is critical for both activation and amplification of the complement response, its allosteric inhibition likely represents a fundamental contribution to the overall immune evasion strategy of S. aureus.

[1]  Robert B Sim,et al.  Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases , 2005, Nature Immunology.

[2]  John D Lambris,et al.  Characterization of Ehp, a Secreted Complement Inhibitory Protein from Staphylococcus aureus* , 2007, Journal of Biological Chemistry.

[3]  John D Lambris,et al.  Hydrogen/deuterium exchange mass spectrometry: potential for investigating innate immunity proteins. , 2007, Advances in experimental medicine and biology.

[4]  John D Lambris,et al.  Exploring the complement interaction network using surface plasmon resonance. , 2007, Advances in experimental medicine and biology.

[5]  N. Goodey,et al.  Allosteric regulation and catalysis emerge via a common route. , 2008, Nature chemical biology.

[6]  K. Novotný World , 2014, World Statistics Pocketbook (Ser. V).

[7]  Masao Kakudo,et al.  Small Angle Scattering of X-Rays , 1968 .

[8]  John D Lambris,et al.  Structure of Compstatin in Complex with Complement Component C3c Reveals a New Mechanism of Complement Inhibition* , 2007, Journal of Biological Chemistry.

[9]  D. Myszka,et al.  Improving biosensor analysis , 1999, Journal of molecular recognition : JMR.

[10]  Greg L. Hura,et al.  X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. , 2011, Quarterly reviews of biophysics.

[11]  L. Mayne,et al.  Helical structure and stability in human apolipoprotein A-I by hydrogen exchange and mass spectrometry , 2009, Proceedings of the National Academy of Sciences.

[12]  J. Vernachio,et al.  Inhibition of complement activation by a secreted Staphylococcus aureus protein. , 2004, The Journal of infectious diseases.

[13]  John D Lambris,et al.  Cutting Edge: Members of the Staphylococcus aureus Extracellular Fibrinogen-Binding Protein Family Inhibit the Interaction of C3d with Complement Receptor 21 , 2008, The Journal of Immunology.

[14]  J. Köhl,et al.  Staphylococcal complement evasion by various convertase-blocking molecules , 2007, The Journal of experimental medicine.

[15]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[16]  J. Richter,et al.  The Staphylococcus aureus Protein Sbi Acts as a Complement Inhibitor and Forms a Tripartite Complex with Host Complement Factor H and C3b , 2008, PLoS pathogens.

[17]  John D Lambris,et al.  Complement-targeted therapeutics , 2007, Nature Biotechnology.

[18]  John D Lambris,et al.  Structure of complement fragment C 3 b – factor H and implications for host protection by complement regulators , 2009 .

[19]  Dmitri I. Svergun,et al.  Determination of the regularization parameter in indirect-transform methods using perceptual criteria , 1992 .

[20]  A. Koster,et al.  Insights into complement convertase formation based on the structure of the factor B‐cobra venom factor complex , 2009, The EMBO journal.

[21]  Karolin Luger,et al.  Structural determinants for generating centromeric chromatin , 2004, Nature.

[22]  S. Perkins,et al.  Constrained solution scattering modelling of human antibodies and complement proteins reveals novel biological insights , 2009, Journal of The Royal Society Interface.

[23]  Sheng Li,et al.  Vibrio cholerae toxin-coregulated pilus structure analyzed by hydrogen/deuterium exchange mass spectrometry. , 2008, Structure.

[24]  D. Uhrín,et al.  Disease-associated Sequence Variations Congregate in a Polyanion Recognition Patch on Human Factor H Revealed in Three-dimensional Structure* , 2006, Journal of Biological Chemistry.

[25]  E. Brown,et al.  Identification and Characterization of the C3 Binding Domain of the Staphylococcus aureus Extracellular Fibrinogen-binding Protein (Efb)* , 2004, Journal of Biological Chemistry.

[26]  R. Nussinov,et al.  Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms , 2009, Molecular bioSystems.

[27]  D. Ricklin,et al.  Structural and functional implications of the alternative complement pathway C 3 convertase stabilized by a staphylococcal inhibitor , 2009 .

[28]  Daniel Ricklin,et al.  Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry. , 2008, Molecular immunology.

[29]  J. Thornton,et al.  Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.

[30]  B. Garcia,et al.  Convertase Inhibitory Properties of Staphylococcal Extracellular Complement-binding Protein* , 2010, The Journal of Biological Chemistry.

[31]  John A Tainer,et al.  Improving small-angle X-ray scattering data for structural analyses of the RNA world. , 2010, RNA.

[32]  K. Preissner,et al.  The anti-inflammatory activities of Staphylococcus aureus. , 2007, Trends in immunology.

[33]  Nurit Haspel,et al.  Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb‐C and its complement target C3d , 2008, Protein science : a publication of the Protein Society.

[34]  Daniel Ricklin,et al.  A structural basis for complement inhibition by Staphylococcus aureus , 2007, Nature Immunology.

[35]  John D. Lambris,et al.  Complement evasion by human pathogens , 2008, Nature Reviews Microbiology.

[36]  Andrej Sali,et al.  FoXS: a web server for rapid computation and fitting of SAXS profiles , 2010, Nucleic Acids Res..

[37]  Thomas Walz,et al.  Structural transitions of complement component C3 and its activation products , 2006, Proceedings of the National Academy of Sciences.

[38]  P. Hass,et al.  Structure of C3b in complex with CRIg gives insights into regulation of complement activation , 2006, Nature.

[39]  Greg L. Hura,et al.  Structure and flexibility within proteins as identified through small angle X-ray scattering. , 2009, General physiology and biophysics.

[40]  John A. Tainer,et al.  Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS) , 2009, Nature Methods.

[41]  Piet Gros,et al.  Complement driven by conformational changes , 2008, Nature Reviews Immunology.

[42]  D. Ricklin,et al.  A Molecular Insight into Complement Evasion by the Staphylococcal Complement Inhibitor Protein Family1 , 2009, The Journal of Immunology.

[43]  Piet Gros,et al.  Structure of C3b reveals conformational changes that underlie complement activity , 2006, Nature.

[44]  Virgil L. Woods,et al.  Protein structure change studied by hydrogen-deuterium exchange, functional labeling, and mass spectrometry , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  B. Paul Morgan,et al.  Molecular Dissection of Interactions between Components of the Alternative Pathway of Complement and Decay Accelerating Factor (CD55)* , 2005, Journal of Biological Chemistry.

[46]  A. Conde Staphylococcus aureus infections. , 1998, The New England journal of medicine.